The Financial Express

Piramal, Anthem, or Cohance: Which CDMO stock has highest exposure to $20 billion ADC market?

India’s CDMO race is entering a specialised new phase as Piramal Pharma, Anthem Biosciences and Cohance Lifesciences build ...